Published in Mol Cell Neurosci on April 01, 2004
A primate model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci (2008) 1.56
Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol (2007) 1.31
White matter astrocytes in health and disease. Neuroscience (2013) 1.07
Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION). Brain Res (2009) 1.06
Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Am J Pathol (2006) 0.97
A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach. J Neurochem (2007) 0.87
Cholecalciferol (vitamin D₃) improves myelination and recovery after nerve injury. PLoS One (2013) 0.85
Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice. Am J Pathol (2010) 0.84
Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs. Front Behav Neurosci (2011) 0.84
Identification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approach. PLoS One (2012) 0.83
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury. J Neuroinflammation (2014) 0.80
Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology. Front Cell Neurosci (2016) 0.78
Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood-optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION). Dis Model Mech (2016) 0.77
Differential expression of secreted phosphoprotein 1 in the motor cortex among primate species and during postnatal development and functional recovery. PLoS One (2013) 0.77
Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair. Front Cell Dev Biol (2016) 0.77
17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss. Neurobiol Dis (2010) 0.76
Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex. J Exp Med (2017) 0.75
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases. J Immunol Res (2016) 0.75
Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis. Cell Mol Neurobiol (2017) 0.75
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med (2005) 5.05
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol (2006) 2.74
CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol (2002) 2.38
Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A (2007) 1.71
TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol (2007) 1.48
Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med (2009) 1.44
Deriving a germinal center lymphocyte migration model from two-photon data. J Exp Med (2008) 1.44
Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase. J Med Chem (2005) 1.42
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol (2004) 1.39
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br J Pharmacol (2004) 1.38
Germinal center B cells govern their own fate via antibody feedback. J Exp Med (2013) 1.36
Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol (2010) 1.36
Multiple roles for slits in the control of cell migration in the rostral migratory stream. J Neurosci (2004) 1.32
Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation (2006) 1.31
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis (2010) 1.28
cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain (2003) 1.13
Deep sequencing of phage display libraries to support antibody discovery. Methods (2013) 1.11
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc Res (2003) 1.07
An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. J Leukoc Biol (2008) 1.07
Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci (2002) 1.06
Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol (2009) 1.05
ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda. Eur J Dermatol (2004) 1.05
Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells. J Biotechnol (2012) 1.05
Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelination. J Neurosci Res (2002) 1.01
Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J Biol Chem (2007) 1.00
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. J Immunol (2003) 0.99
IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease. J Immunol (2002) 0.99
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. Eur Heart J (2011) 0.98
Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J Neuroimmunol (2006) 0.96
Osteopontin is not required for the development of Th1 responses and viral immunity. J Immunol (2005) 0.96
GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system. Glia (2008) 0.95
Chemical inducers and transcriptional markers of oligodendrocyte differentiation. J Neurosci Res (2010) 0.94
Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin Neurol Neurosurg (2004) 0.93
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity. Cancer Chemother Pharmacol (2008) 0.93
Effect of Toll-like receptor 4 blockade on pulmonary inflammation caused by mechanical ventilation and bacterial endotoxin. Exp Lung Res (2008) 0.93
Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther (2007) 0.93
3alpha,5alpha-Tetrahydroprogesterone (allopregnanolone) and gamma-aminobutyric acid: autocrine/paracrine interactions in the control of neonatal PSA-NCAM+ progenitor proliferation. J Neurosci Res (2004) 0.90
A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology. J Biomol Screen (2003) 0.89
Chemokines derived from soluble fusion proteins expressed in Escherichia coli are biologically active. Biochem Biophys Res Commun (2005) 0.88
Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences. PLoS One (2012) 0.88
Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer. PLoS One (2013) 0.87
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor. Trends Endocrinol Metab (2010) 0.86
Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3. PLoS One (2009) 0.86
3D and 4D imaging of immune cells in vitro and in vivo. Histochem Cell Biol (2008) 0.85
The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis. J Natl Cancer Inst (2002) 0.85
Robust recombinant FcRn production in mammalian cells enabling oriented immobilization for IgG binding studies. J Immunol Methods (2011) 0.85
Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions. Neuropathol Appl Neurobiol (2014) 0.83
Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface. Mol Pharmacol (2013) 0.82
Substrate determinants in the C99 juxtamembrane domains differentially affect γ-secretase cleavage specificity and modulator pharmacology. J Neurochem (2013) 0.82
De novo isolation of antibodies with pH-dependent binding properties. MAbs (2015) 0.81
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments. Arthritis Rheum (2012) 0.81
Development of a small-molecule screening method for inhibitors of cellular response to myostatin and activin A. J Biomol Screen (2013) 0.81
Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro. Exp Neurol (2003) 0.81
In vivo processing of CXCL12α/SDF-1α after intravenous and subcutaneous administration to mice. Proteomics (2010) 0.81
Detection and identification of plasma proteins that bind GlialCAM using ProteinChip arrays, SELDI-TOF MS, and nano-LC MS/MS. Proteomics (2008) 0.80
A high-throughput mammalian protein expression, purification, aliquoting and storage pipeline to assemble a library of the human secretome. Comb Chem High Throughput Screen (2006) 0.80
Control of cell survival and proliferation of postnatal PSA-NCAM(+) progenitors. Mol Cell Neurosci (2003) 0.80
Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade. Transplantation (2015) 0.79
Comparing CDRH3 diversity captured from secondary lymphoid organs for the generation of recombinant human antibodies. MAbs (2013) 0.79
MIG--differential gene expression in mouse brain endothelial cells. Neuroreport (2002) 0.79
Epitope-dependent inhibition of T cell activation by the Ea transgene: an explanation for transgene-mediated protection from murine lupus. J Immunol (2004) 0.78
Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases. Swiss Med Wkly (2012) 0.78
Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist. J Pharmacol Exp Ther (2007) 0.78
Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease. Blood (2010) 0.77
IL-18-independent cytotoxic T lymphocyte activation and IFN-gamma production during experimental acute graft-versus-host disease. Int Immunol (2002) 0.77
Characterization of a surrogate murine antibody to model anti-human CD3 therapies. MAbs (2013) 0.77
The 16th International Conference on Lymphatic Tissues and Germinal Centers in Immune Responses. Eur J Immunol (2009) 0.77
An adiponectin-like molecule with antidiabetic properties. Endocrinology (2009) 0.77
Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif. FEBS J (2014) 0.76
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy. ChemMedChem (2015) 0.76
Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system. Protein Expr Purif (2010) 0.76
Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor. BMC Pregnancy Childbirth (2007) 0.76
High-throughput screening for small-molecule inhibitors of Staphylococcus epidermidis RP62a biofilms. J Biomol Screen (2013) 0.76
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists. J Med Chem (2005) 0.76
Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors. MAbs (2014) 0.75
New biological therapies from the human genome. Expert Opin Drug Discov (2007) 0.75
Extracellular lysosome-associated membrane protein-1 (LAMP-1) mediates autoimmune disease progression in the NOD model of type 1 diabetes. Eur J Immunol (2005) 0.75
IL-17F co-expression improves cell growth characteristics and enhances recombinant protein production during CHO cell line engineering. Biotechnol Bioeng (2012) 0.75
[Adult subventricular zone neural stem cells and repair of demyelinating diseases]. Med Sci (Paris) (2003) 0.75